Blog

Platform-Agnostic SNP Genotyping and Allele-Specific PCR with PACE Master Mixes

PACE® – What is allele-specific PCR?

Allele-specific PCR distinguishes between two versions of a single DNA base by using primers that match one allele exactly. Only the matching primer extends efficiently, and a fluorescent reporter records which one did. This makes it the standard method for SNP genotyping in plant and animal breeding, where thousands of samples are screened against a small number of known markers. PACE® is the genotyping chemistry 3CR Bioscience supplies for this method, and it runs on every common PCR platform from 96-well plates to microfluidic chips.

Why breeding programmes use allele-specific PCR

SNP genotyping and allele-specific PCR are cornerstones of modern genetic analysis, allowing scientists to track and monitor genetic variations with pinpoint accuracy. With PACE genotyping reagents, breeders track known variants across large populations at a low cost per data point.

Which platforms PACE supports

PACE genotyping master mixes are platform agnostic for precision PCR genotyping. PACE’s patented genotyping chemistry has been meticulously designed to perform across all PCR genotyping platforms and reaction volumes, providing consistently accurate results. In addition, all PACE genotyping mixes are supplied with Standard, High, Low, or No ROX normalisation dye options for optimal performance.

PlatformFormatSuitable
Standard PCR plates96-well, 384-well, 1536-wellYes
Array Tape®Continuous tapeYes
Standard Biotools Biomark X9Microfluidic chip, nanolitreYes
Standard Biotools Biomark HDMicrofluidic chip, nanolitreYes
ROX normalisation optionsStandard, High, Low, NoneAll four supplied

Reaction volumes and plate formats

PACE genotyping master mixes are compatible with all major PCR genotyping platforms, including 96-, 384-, and 1536-well PCR plates, and Array Tape®. PACE generates accurate data regardless of the reaction volume. PACE is suitable for Biomark X9 and Biomark HD automated, chip-based PCR systems from Standard Biotools (formerly Fluidigm) that use microfluidics technology to process samples at nanoliter-scale volumes.

Running PACE on microfluidics with the Biomark X9

By harnessing the power of microfluidics technology, PACE enables high-throughput, scalable SNP and Indel marker development and screening. This makes it an ideal solution for large-scale, cost-effective allele-specific PCR analysis and SNP genotyping using microfluidics platforms such as the Biomark X9 System from Standard Biotools. The Biomark platforms offer automated, high-performance PCR at nanolitre volumes and simultaneous monitoring of markers across numerous samples, drastically reducing both time and cost.

Breeders and researchers alike can develop platform-agnostic SNP marker sets on these and similar high-throughput platforms, utilising PACE genotyping reagents for universal reporting. PACE is compatible with multiple other throughput platforms downstream to ensure future-proof automation, and reproducibility.

Results from 96 samples across 96 SNPs

An application note produced with Standard Biotools records PACE performance on the Biomark X9 System. A public research institute genotyped 96 samples across 96 SNPs at nanolitre volumes. The data show tight clustering and high concordance between calls, which confirms that the chemistry holds its accuracy when the reaction volume drops to the microfluidic scale. The full application note is available from 3CR Bioscience.

Next-generation sequencing (NGS) for SNP discovery followed by PACE SNP marker saturation in quantitative trait loci (QTL) intervals is a great, real-world example of the utility of this combination. Designing PACE genotyping assays against SNP variants, high-throughput screening using the Biomark X9 System, and genotyping recombinants on lower-throughput platforms demonstrates the versatility in research and breeding applications.

Figure 1. Example data of 96 samples over 96 SNPs. Data calling (A) from the heat map (B) shows tight clustering and a high concordance of SNPs in the principal component analysis plot. Actual data from a high-throughput genotyping and sequencing technology service provider for a public research institute using PACE genotyping with the Biomark X9.

Frequently asked questions

What is the difference between allele-specific PCR and sequencing?

Allele-specific PCR tests a known set of variants and returns a genotype call per marker. Sequencing reads the sequence itself and discovers variants that are not yet known. Breeding programmes normally use sequencing once to find markers, then allele-specific PCR to screen populations against those markers at a far lower cost per sample.

Can allele-specific PCR run on crude DNA extracts?

Yes, with an inhibitor resistant chemistry. PACE 2.0 Genotyping Master Mix is formulated for crudely extracted template and removes the purification step.

How many samples can be genotyped in one run?

This depends on the platform. A 1536-well plate holds 1,536 reactions, and microfluidic systems such as the Biomark X9 process 96 samples against 96 markers in a single chip.

Summary

Allele-specific PCR remains the most economical route to SNP data once the markers are known. PACE runs the method on every common platform, from 96-well plates through 1536-well formats to the Biomark X9 microfluidic system, with the same chemistry and the same ROX options throughout. That means a breeding programme can change throughput or instrument without revalidating its assays.

MORE POSTS

TURBO GRINDER USER GUIDE
Learn how to install, configure, operate and maintain the Turbo Grinder with step-by-step instructions, software setup, troubleshooting tips and best practices for reliable high-throughput sample homogenisation.
PACE® GENOTYPING MASTER MIX – USER GUIDE
Get everything you need to run successful PACE® genotyping reactions, from DNA and assay setup to thermal cycling, fluorescence detection and genotype interpretation.
PACE® NANO GENOTYPING MASTER MIX TRIAL KIT USER GUIDE
Everything you need to get started with PACE® Nano Genotyping—from reaction setup and ROX compatibility to endpoint detection and data interpretation—in one practical user guide.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Resolve Genotyping Challenges. With One Practical Guide.

From failed amplification to scattered cluster plots — this guide provides structured, expert-backed solutions for the 7 most common PACE® genotyping issues.

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
I’d like to sign up for the newsletter

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager

For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.

Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.

Daniel LawsonMarketing Manager
Daniel is a strategically minded marketing and communications professional with over a decade of experience delivering integrated, multi-channel campaigns across healthcare, legal and not-for-profit sectors. He has a strong track record in building brand visibility, driving engagement and supporting revenue growth through audience-focused marketing.
Prior to joining 3CR Bioscience in 2025, Daniel held senior marketing roles where he led strategic communications, managed brand development and delivered high-impact digital and content campaigns. His experience spans SEO, CRM, PR, events and stakeholder engagement, with a particular strength in translating complex messages into clear, compelling content.
At 3CR Bioscience, Daniel is responsible for shaping and executing the company’s marketing strategy, enhancing brand presence and supporting commercial growth through targeted, data-driven campaigns.